Evidence map›Paper›PMID 31239494›Full record

ArticleLeukemia2019

Correction: S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells.

K Vrzalikova, M Ibrahim, M Vockerodt, T Perry, S Margielewska, L Lupino, E Nagy, E Soilleux, D Liebelt, R Hollows and 12 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

K VrzalikovaInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
M IbrahimInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
M VockerodtInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
T PerryInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
S MargielewskaInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
L LupinoInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
E NagyInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
E SoilleuxDepartment of Cellular Pathology, John Radcliffe Hospital, Oxford, UK.
D LiebeltInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
R HollowsInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
A LastInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
G ReynoldsInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
M AbdullahInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
H CurleyInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
M CareLeeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
D KrappmannResearch Unit Cellular Signal Integration, Helmholtz Zentrum München, Neuherberg, Germany.
R ToozeLeeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
J AllegoodDepartment of Biochemistry and Molecular Biology and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
S SpiegelDepartment of Biochemistry and Molecular Biology and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
W WeiInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
C B J WoodmanInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
P G MurrayInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. p.g.murray@bham.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31239494
PMCPMC7609288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.